tiprankstipranks
Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289)
HKEX:2289
Hong Kong Market
2289
Charmacy Pharmaceutical Co., Ltd. Class H
RESEARCH TOOLSreports

Charmacy Pharmaceutical Co., Ltd. Class H (2289) Stock Price & Analysis

0 Followers

2289 Stock Chart & Stats

Day’s RangeHK$0 - HK$0
52-Week RangeHK$5.76 - HK$19.53
Previous CloseHK$8.6
Volume5.00K
Average Volume (3M)98.29K
Market Cap
HK$928.80M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)16.4
Beta0.62
Aug 26, 2024
EPS EstimateN/A
Dividend Yield3.83%
Share Statistics
EPS (TTM)0.53
Shares Outstanding108,000,000
10 Day Avg. Volume1,050
30 Day Avg. Volume98,290
Standard Deviation0.06
R-Squared0.01
Alpha-0.00469
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Charmacy Pharmaceutical Co., Ltd. Class H News

2289 FAQ

What was Charmacy Pharmaceutical Co., Ltd. Class H’s price range in the past 12 months?
Charmacy Pharmaceutical Co., Ltd. Class H lowest stock price was HK$5.76 and its highest was HK$19.53 in the past 12 months.
    What is Charmacy Pharmaceutical Co., Ltd. Class H’s market cap?
    Currently, no data Available
    When is Charmacy Pharmaceutical Co., Ltd. Class H’s upcoming earnings report date?
    Charmacy Pharmaceutical Co., Ltd. Class H’s upcoming earnings report date is Aug 26, 2024 which is in 49 days.
      How were Charmacy Pharmaceutical Co., Ltd. Class H’s earnings last quarter?
      Charmacy Pharmaceutical Co., Ltd. Class H released its earnings results on Mar 28, 2024. The company reported HK$0.25 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.25.
        Is Charmacy Pharmaceutical Co., Ltd. Class H overvalued?
        According to Wall Street analysts Charmacy Pharmaceutical Co., Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Charmacy Pharmaceutical Co., Ltd. Class H pay dividends?
          Charmacy Pharmaceutical Co., Ltd. Class H pays a Annually dividend of HK$0.32 which represents an annual dividend yield of 3.83%. See more information on Charmacy Pharmaceutical Co., Ltd. Class H dividends here
            What is Charmacy Pharmaceutical Co., Ltd. Class H’s EPS estimate?
            Charmacy Pharmaceutical Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Charmacy Pharmaceutical Co., Ltd. Class H have?
            Charmacy Pharmaceutical Co., Ltd. Class H has 108,000,000 shares outstanding.
              What happened to Charmacy Pharmaceutical Co., Ltd. Class H’s price movement after its last earnings report?
              Charmacy Pharmaceutical Co., Ltd. Class H reported an EPS of HK$0.25 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.098%.
                Which hedge fund is a major shareholder of Charmacy Pharmaceutical Co., Ltd. Class H?
                Currently, no hedge funds are holding shares in HK:2289
                ---

                Charmacy Pharmaceutical Co., Ltd. Class H Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                7.41%
                12-Months-Change

                Fundamentals

                Return on Equity
                8.57%
                Trailing 12-Months
                Asset Growth
                11.13%
                Trailing 12-Months
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis